首页> 外文OA文献 >Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties.
【2h】

Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties.

机译:两种交叉反应性单克隆抗体可识别脑膜炎奈瑟氏球菌因子H结合蛋白上的重叠表位,但具有不同的功能特性。

摘要

Factor H binding protein (fHbp) is one of the main antigens of the 4-component meningococcus B (4CMenB) multicomponent vaccine against disease caused by serogroup B Neisseria meningitidis (MenB). fHbp binds the complement down-regulating protein human factor H (hfH), thus resulting in immune evasion. fHbp exists in 3 variant groups with limited cross-protective responses. Previous studies have described the generation of monoclonal antibodies (mAbs) targeting variant-specific regions of fHbp. Here we report for the first time the functional characterization of two mAbs that recognize a wide panel of fHbp variants and subvariants on the MenB surface and that are able to inhibit fHbp binding to hfH. The antigenic regions targeted by the two mAbs were accurately mapped by hydrogen-deuterium exchange mass spectrometry (HDX-MS), revealing partially overlapping epitopes on the N terminus of fHbp. Furthermore, while none of the mAbs had bactericidal activity on its own, a synergistic effect was observed for each of them when tested by the human complement serum bactericidal activity (hSBA) assay in combination with a second nonbactericidal mAb. The bases underlying fHbp variant cross-reactivity, as well as inhibition of hfH binding and cooperativity effect observed for the two mAbs, are discussed in light of the mapped epitopes.
机译:H因子结合蛋白(fHbp)是针对由B群脑膜炎奈瑟氏球菌(MenB)引起的疾病的4组分脑膜炎球菌B(4CMenB)多组分疫苗的主要抗原之一。 fHbp结合补体下调蛋白人类因子H(hfH),从而导致免疫逃逸。 fHbp存在于3个变异的组中,交叉保护反应有限。先前的研究已经描述了针对fHbp的变异特异性区域的单克隆抗体(mAb)的产生。在这里,我们首次报告了两个mAb的功能表征,这些mAb识别MenB表面上的fHbp变体和亚变体种类繁多,并且能够抑制fHbp与hfH结合。通过氢-氘交换质谱(HDX-MS)精确定位了这两个mAb靶向的抗原区域,揭示了fHbp N末端的部分重叠表位。此外,尽管没有一个mAb本身具有杀菌活性,但是当通过人补体血清杀菌活性(hSBA)分析与第二种非杀菌mAb结合进行测试时,对每个单克隆抗体均具有协同作用。根据映射的表位,讨论了fHbp变异交叉反应的基础以及观察到的针对两种mAb的hfH结合和协同作用的抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号